TITLE: Monitoring PSA Scores for Prostate Cancer Treatment
CME credit awarded: 1.0
CE# (if applicable): 00192-EDII-789
CE credit issued: 1.25
Expiration Date: May 1, 2020 Reviewed / Reapproved: December 11, 2020
New Expiration Date: December 1, 2021
Author/Content Specialist: Todd Sherrer, M.D., Urologist, Urologic
Disclosure: Todd Sherrer, M.D. has indicated that there are no disclosures to be made regarding this presentation.
The planning committee has also indicated that they have no disclosures.
Discuss the use of prostate-specific antigen (PSA) in screening for and monitoring of prostate cancer.